Diet blues: Methodological problems in comparing non-pharmacological weight management programs for patients with schizophrenia

References

• Harris EC, Barraclough B. Excess mortality of mental disorder. Br J Psychiatry 1998; 173: 11–53
   PubMed Web of Science ®Google Scholar
• Kasper, S. Metabolisches Syndrom bei Patienten mit seelischen Erkrankungen. Konsensus-Statement. Clin Psy 2005 ( Sonderausgabe p 16–19).
   Google Scholar
• Goff, DC, Cather, C, Evins, AE, Henderson, DC, Freudenreich, O, Copeland, PM, , et al. Medical morbidity and mortality in schizophrenia: guidelines for psychiatrists. J Clin Psychiatry 2005;66((2)): 183–94; quiz 147:273–4.
   Google Scholar
• Winkler D, Pjrek E, Kasper S. Metabolisches Syndrom. Zunehmende Herausforderung. Clin Psy 2005; 4: 16–19
   Google Scholar
• Homel P, Casey D, Allison DB. Changes in body mass index for individuals with and without schizophrenia, 1987–1996. Schizophr Res 2002; 55(3)277–84
   Google Scholar
• Coodin S. Body mass index in persons with schizophrenia. Can J Psychiatry 2001; 46(6)549–55
   PubMed Web of Science ®Google Scholar
• Fontaine KR, Heo M, Harrigan EP, Shear CL, Lakshminarayannan M, Casey DE, Allison DB. Estimating the consequences of antipsychotic induced weight gain on health and mortality rate. Psychiatry Res 2001; 101(3)277–88
   PubMedGoogle Scholar
• Faulkner, G,.Cohn, T,.Remington, G. Interventions to reduce weight gain in schizophrenia. Cochrane Database Syst Rev 2007(1):CD005148.
   Google Scholar
• Allison DB, Mentore JL, Heo M, Chandler LP, Cappelleri JC, Infante MC, et al. Antipsychotic-induced weight gain: a comprehensive research synthesis. Am J Psychiatry 1999; 156(11)1686–96
   PubMed Web of Science ®Google Scholar
• Citrome L. Interpreting and applying the EUFEST results using number needed to treat: antipsychotic effectiveness in first-episode schizophrenia. Int J Clin Pract 2008; 62(5)837–40
   Google Scholar
• Weiden PJ. Switching antipsychotics as a treatment strategy for antipsychotic-induced weight gain and dyslipidemia. J Clin Psychiatry 2007; 68(Suppl 4)34–9
   Google Scholar
• National Institutes of Health. Comparison of antipsychotics for metabolic problems (CAMP) in the treatment of people with schizophrenia or schizoaffective disorder. http://www.clinicaltrials.gov. 2008.
   Google Scholar
• Shaw, KA, O'Rourke, P, Del Mar, C, Kenardy, J. Psychological interventions for overweight or obesity. Cochrane Database Syst Rev 2005; (2): CD003818.
   Google Scholar
• Rotatori AF, Fox R, Wicks A. Weight loss with psychiatric residents in a behavioral self control program. Psychol Rep 1980; 46(2)483–6
   PubMed Web of Science ®Google Scholar
• Ball MP, Coons VB, Buchanan RW. A program for treating olanzapine-related weight gain. Psychiatr Serv 2001; 52(7)967–9
   PubMed Web of Science ®Google Scholar
• Aquila R. Management of weight gain in patients with schizophrenia. J Clin Psychiatry 2002; 63(Suppl 4)33–6
   PubMedGoogle Scholar
• Vreeland B, Minsky S, Menza M, Rigassio Radler D, Roemheld-Hamm B, Stern R. A program for managing weight gain associated with atypical antipsychotics. Psychiatr Serv 2003; 54(8)1155–7
   PubMed Web of Science ®Google Scholar
• Menza M, Vreeland B, Minsky S, Gara M, Radler DR, Sakowitz M. Managing atypical antipsychotic-associated weight gain: 12-month data on a multimodal weight control program. J Clin Psychiatry 2004; 65(4)471–7
   PubMed Web of Science ®Google Scholar
• Fogarty M, Happell B, Pinikahana J. The benefits of an exercise program for people with schizophrenia: a pilot study. Psychiatr Rehabil J 2004; 28(2)173–6
   PubMed Web of Science ®Google Scholar
• Archie S, Wilson JH, Osborne S, Hobbs H, McNiven J. Pilot study: access to fitness facility and exercise levels in olanzapine-treated patients. Can J Psychiatry 2003; 48(9)628–32
   PubMed Web of Science ®Google Scholar
• Littrell KH, Hilligoss NM, Kirshner CD, Petty RG, Johnson CG. The effects of an educational intervention on antipsychotic-induced weight gain. J Nurs Scholarsh 2003; 35(3)237–41
   PubMed Web of Science ®Google Scholar
• O'Melia J, Shaw J, Dickinson C. A Meaningful Day Group approach to weight gain from antipsychotic medication. J Psychiatr Ment Health Nurs 2004; 11(1)112–6
   Google Scholar
• Kalarchian MA, Marcus MD, Levine MD, Haas GL, Greeno CG, Weissfeld LA, et al. Behavioral treatment of obesity in patients taking antipsychotic medications. J Clin Psychiatry 2005; 66(8)1058–63
   PubMed Web of Science ®Google Scholar
• Brar JS, Ganguli R, Pandina G, Turkoz I, Berry S, Mahmoud R. Effects of behavioral therapy on weight loss in overweight and obese patients with schizophrenia or schizoaffective disorder. J Clin Psychiatry 2005; 66(2)205–12
   PubMed Web of Science ®Google Scholar
• Evans S, Newton R, Higgins S. Nutritional intervention to prevent weight gain in patients commenced on olanzapine: a randomized controlled trial. Aust NZ J Psychiatry 2005; 39(6)479–86
   PubMed Web of Science ®Google Scholar
• Pendlebury J, Haddad P, Dursun S. Evaluation of a behavioural weight management programme for patients with severe mental illness: 3 year results. Hum Psychopharmacol 2005; 20(6)447–8
   PubMed Web of Science ®Google Scholar
• Beebe LH, Tian L, Morris N, Goodwin A, Allen SS, Kuldau J. Effects of exercise on mental and physical health parameters of persons with schizophrenia. Issues Ment Health Nurs 2005; 26(6)661–76
   PubMedGoogle Scholar
• Weber M, Wyne K. A cognitive/behavioral group intervention for weight loss in patients treated with atypical antipsychotics. Schizophr Res 2006; 83(1)95–101
   PubMed Web of Science ®Google Scholar
• Kwon JS, Choi JS, Bahk WM, Yoon Kim C, Hyung Kim C, Chul Shin Y, et al. Weight management program for treatmentemergent weight gain in olanzapine-treated patients with schizophrenia or schizoaffective disorder: A 12-week randomized controlled clinical trial. J Clin Psychiatry 2006; 67(4)547–53
   PubMed Web of Science ®Google Scholar
• Centorrino F, Wurtman JJ, Duca KA, Fellman VH, Fogarty KV, Berry JM, et al. Weight loss in overweight patients maintained on atypical antipsychotic agents. Int J Obes (London) 2006; 30(6)1011–6
   PubMed Web of Science ®Google Scholar
• Voruganti LN, Whatham J, Bard E, Parker G, Babbey C, Ryan J, et al. Going beyond: an adventure-and recreation-based group intervention promotes well-being and weight loss in schizophrenia. Can J Psychiatry 2006; 51(9)575–80
   PubMed Web of Science ®Google Scholar
• McKibbin CL, Patterson TL, Norman G, Patrick K, Jin H, Roesch S, et al. A lifestyle intervention for older schizophrenia patients with diabetes mellitus: a randomized controlled trial. Schizophr Res 2006; 86(1-3)36–44
   PubMed Web of Science ®Google Scholar
• Mauri M, Castrogiovanni S, Simoncini M, Iovieno N, Miniati M, Rossi A, et al. Effects of an educational intervention on weight gain in patients treated with antipsychotics. J Clin Psychopharmacol 2006; 26(5)462–6
   PubMed Web of Science ®Google Scholar
• Wirshing DA, Smith RA, Erickson ZD, Mena SJ, Wirshing WC. A wellness class for inpatients with psychotic disorders. J Psychiatr Pract 2006; 12(1)24–9
   PubMedGoogle Scholar
• Klam J, McLay M, Grabke D. Personal empowerment program: addressing health concerns in people with schizophrenia. J Psychosoc Nurs Ment Health Serv 2006; 44(8)20–8
   Google Scholar
• Jean-Baptiste M, Tek C, Liskov E, Chakunta UR, Nicholls S, Hassan AQ, et al. A pilot study of a weight management program with food provision in schizophrenia. Schizophr Res 2007; 96(1)198–205
   Google Scholar
• Pendlebury J, Bushe CJ, Wildgust HJ, Holt RI. Long-term maintenance of weight loss in patients with severe mental illness through a behavioural treatment programme in the UK. Acta Psychiatr Scand 2007; 115(4)286–94
   Google Scholar
• Milano W, Grillo F, Del Mastro A, De Rosa M, Sanseverino B, Petrella C, et al. Appropriate intervention strategies for weight gain induced by olanzapine: a randomized controlled study. Adv Ther 2007; 24(1)123–34
   PubMed Web of Science ®Google Scholar
• Wu MK, Wang CK, Bai YM, Huang CY, Lee SD. Outcomes of obese, clozapine-treated inpatients with schizophrenia placed on a six-month diet and physical activity program. Psychiatr Serv 2007; 58(4)544–50
   PubMed Web of Science ®Google Scholar
• Nguyen CT, Yu B, Maguire G. Update on atypicals: pre-emptive tactics to reduce weight gain. Curr Psychiatry 2003; 2: 58–62
   Google Scholar
• Umbricht D, Flury H, Bridler R. Cognitive behavior therapy for weight gain. Am J Psychiatry 2001; 158(6)971
   Google Scholar
• Merriman S, Riddel D, Thrush N. Wonderful me! Evaluation of a multidisciplinary therapy package for overweight psychiatric patients. Br J Therapy Rehab 1995; 2: 531–535
   Google Scholar
• Knox JM. A study of weight reducing diets in psychiatric in-patients. Br J Psychiatry 1980; 136: 287–9
   PubMed Web of Science ®Google Scholar
• McCreadie RG, et al. Dietary improvement in people with schizophrenia: randomised controlled trial. Br J Psychiatry 2005; 187: 346–51
   PubMed Web of Science ®Google Scholar
• Ganguli R, Brar JS. Prevention of weight gain by behavioral interventions in patients starting novel antipsychotics. Schizophr Bull 2005; 31: 561–62
   Google Scholar
• Heimberg C, Gallacher F, Gur RC, Gur RE. Diet and gender moderate clozapine-related weight gain. Hum Psychopharmacol 1995; 10: 367–71
   Web of Science ®Google Scholar
• Smith S, Yeomans D, Bushe CJ, Eriksson C, Harrison T, Holmes R, et al. A well-being programme in severe mental illness. Reducing risk for physical ill-health: a postprogramme service evaluation at 2 years. Eur Psychiatry 2007; 22(7)413–8
   PubMed Web of Science ®Google Scholar
• Poulin MJ, Chaput JP, Simard V, Vincent P, Bernier J, Gauthier Y, et al. Management of antipsychotic-induced weight gain: prospective naturalistic study of the effectiveness of a supervised exercise programme. Aust NZ J Psychiatry 2007; 41(12)980–9
   PubMed Web of Science ®Google Scholar
• Bushe CJ, et al. Weight management in a cohort of Irish inpatients with serious mental illness (SMI) using a modular behavioural programme. A preliminary service evaluation. BMC Psychiatry 2008; 8: 76
   Google Scholar
• Lee SJ, Choi EJ, Kwon JS. A naturalistic multicenter trial of a 12-week weight management program for overweight and obese patients with schizophrenia or schizoaffective disorder. J Clin Psychiatry 2008; 69(4)555–62
   PubMed Web of Science ®Google Scholar
• Feeney L, Dempsey J, Moynihan F, Barry S. Changes in body mass indices of patients with schizophrenia 3 years following the introduction of a weight management programme. Ir Med J 2003; 96(9)276–7
   Google Scholar
• Khazaal Y, Fresard E, Rabia S, Chatton A, Rothen S, Pomini V, et al. Cognitive behavioural therapy for weight gain associated with antipsychotic drugs. Schizophr Res 2007; 91(1–3)169–77
   PubMed Web of Science ®Google Scholar
• Harmatz MG, Lapuc P. Behavior modification of overeating in a psychiatric population. J Consult Clin Psychol 1968; 32(5)583–7
   PubMedGoogle Scholar
• Hainer V, Toplak H, Mitrakon A. Treatment modalities of obesity: what fits whom?. Diabetes Care 2008; 31(Suppl 2)269–77
   PubMed Web of Science ®Google Scholar
• Strassnig M, Brar JS, Ganguli R. Self-reported body weight perception and dieting practices in community-dwelling patients with schizophrenia. Schizophr Res 2005; 75(2–3)425–32
   Google Scholar
• Sernyak MJ. Implementation of monitoring and management guidelines for second-generation antipsychotics. J Clin Psychiatry 2007; 68(Suppl 4)14–8
   Google Scholar
• Loh C, Meyer JM, Leckband SG. A comprehensive review of behavioral interventions for weight management in schizophrenia. Ann Clin Psychiatry 2006; 18(1)23–31
   PubMedGoogle Scholar
• Ganguli R. Behavioral therapy for weight loss in patients with schizophrenia. J Clin Psychiatry 2007; 68(Suppl 4)19–25
   PubMed Web of Science ®Google Scholar